Fundraising Fox

MBO+

Private equity

Paris · Growth · 30 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

MBO+ invests alongside managers and entrepreneurs to unlock the full potential of their businesses. Since 2002, the firm has provided strategic resources to help management teams achieve their growth objectives. Its approach is structured around three areas of expertise: Buyout, Buy & Build, and Flex. As a committed investor, the firm also emphasizes positive impact, using its expertise to help build a more sustainable future, and highlights its track record of building business success through partnership with management teams.

Invests inAdvanced ManufacturingSector AgnosticEuropeFranceParis

Source: firm website, verified Aug 18, 2026.

Stage
Growth
HQ
Paris, FR
Instruments
Equity
Founded
2002
Private fund assets
$841M
Tracked investments
20

Team · 30 people

from the firm's website
Alexandre Chaton· Buyout Partnerin
Charles Dubar· Partner Buyout
Franklin Henrot· Flex Partnerin
Olivier Delrieu· Managing Directorin
Paul Vaissié· Flex Partner
Raphaël Lahaye· Buyout Partner
Chloé Miller· Buyout Director
Loïc Grimaud· Buyout Directorin
Marine Cuadra· Flex Directorin
Pauline François-Poncet· Flex Directorin
Adrien Noiret· Associatein
Astrid Legoux· Associate
Eric Dejoie· Supervisory Board Chairmanin
Guillaume Relin· Accountant
Justine Robidoux· Executive Assistant
Ladislas Smia· Head of Sustainabilityin
Laure Vauthrin· Financial Controllerin
Marco Cirillo· Performance Team Director
Martine Dutheil· Assistant & Office Managerin
Quitterie de Wendel· Head of Communicationsin
Richard Broche· Senior Advisorin
Romain Touyé· Investor Relations Analyst
Stan Petiot· Associate
Zoé Tournilhac· Associate

What they invest in

from 5 of 20 portfolio companies

AI & Machine Learning ×2Enterprise Software ×2SaaS ×2Biotech ×1Cleantech ×1Climate Tech ×1Consumer ×1Healthtech ×1

HQs:France×1United States×1

Investments · 20 tracked

founders shown can be your intro path
Add
Caddenz (ex-LT Group)
CardioMEMScookiedatabase.org

Molecular diagnostics company offering clinical PCR systems using automation and microfluidics; acquired by QIAGEN in September 2020.

BiotechHealthtechAlbuquerque, US

Thomas Duensing(Executive Officer)Dennis Hynson(Executive Officer)Janette Phi(Executive Officer)R. Terry Dunlay(Executive Officer, Director)Sundaresh Brahmasandra(Executive Officer)Jeffrey Williams(Executive Officer, Director)

Dayusedayuse.com

Dayuse is an online platform for booking hotel rooms during the day for a few hours (2 to 12 hours) rather than overnight, at rates 30–75% below the nightly price.

ConsumerMarketplacesTravel & Hospitality

Dentylis
Digital Native Group (DNG)
Evesio En
Groupe Bage
Groupe IEF2I Education
HPS International
Icare
Klee Groupkleegroup.com

Klee Group builds custom digital business solutions and consulting services, combining software engineering with AI capabilities for enterprise and public-sector clients.

AI & Machine LearningEnterprise SoftwareSaaS

LEN Médical
Logtrans
Néocamp Group
Norman K
Osmaïaosmaia-group.com

Osmaïa Group is a landscaping company that designs and maintains green spaces across natural, urban, and heritage environments, adding ecological engineering as a complementary expertise.

CleantechClimate TechImpact & Social Good

Praxedopraxedo.com

Praxedo offers web-based field service management software with a companion mobile app for technicians, used to schedule field teams, track activity in real time, and optimize routes.

AI & Machine LearningEnterprise SoftwareSaaS

Salini Immobilier
SYXPERIANE

Frequently asked questions

What stage does MBO+ invest at?
MBO+ invests at the Growth stage.
What sectors does MBO+ focus on?
MBO+ focuses on Advanced Manufacturing, Sector Agnostic.
Where is MBO+ located?
MBO+ is headquartered in Paris, FR.

Images

MBO+ photoMBO+ photoMBO+ photoMBO+ photoMBO+ photoMBO+ photo

Similar investors

Featured in lists